In these models, curcumin analog C1 activated TFEB, promoted autophagy and lysosome biogenesis, degraded APP and Tau aggregates, reduced the levels of Aβ, reversed synaptic dysfunction and improved cognitive deficits. This evidence concerns the gene MAPT and Cognitive impairment.